Psychiatry and Neurology, Neurology · Rochester, NY
NPI
1780671511
Since 2005
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
3
Medicare group memberships
Hospitals
0
Hospital affiliations
2101 Lac de Ville Blvd
Rochester, NY, 14618
Phone (585) 546-7266
Groups this clinician bills Medicare through
Medicare paid, 2024
$639K
32,780 services
Medicare patients, 2024
226
Average age 68
Drug cost, 2024
$4.7M
8,192 prescriptions
Company payments, 2025
$126
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Allen D Pettee was code J0585 (injection, onabotulinumtoxina, 1 unit), 11,000 times for 18 patients. In total Allen D Pettee billed 32,780 services in 37 codes, and Medicare paid $639K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-11-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 11,000 | 18 | $4.49 | $49K |
| 99214 Office E&M - Established | Office | 289 | 175 | $81.91 | $24K |
| 64615 Musculoskeletal | Office | 63 | 21 | $91.81 | $5,784 |
| 99213 Office E&M - Established | Office | 62 | 54 | $50.12 | $3,107 |
| 95886 Electrical Nerve Conductivity | Office | 45 | 23 | $72.55 | $3,265 |
| 99204 Office E&M - New | Office | 21 | 21 | $112.63 | $2,365 |
By year: 2022 $774K for 36,619 services; 2023 $891K for 39,795 services; 2024 $639K for 32,780 services.
Medicare prescription drug claims, 2024
In 2024, the drug Allen D Pettee prescribed most often to Medicare patients was Gabapentin, with 821 prescriptions and refills. In total Allen D Pettee wrote 8,192 Medicare prescriptions that cost $4.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 821 | 1,245 | 148 | $17K |
| Donepezil Hcl Generic | 364 | 563 | 63 | $3,176 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 321 | 586 | 58 | $10K |
| Pregabalin Generic | 262 | 330 | 44 | $6,246 |
| Topiramate Generic | 249 | 425 | 45 | $3,117 |
| Memantine Hcl Generic | 236 | 322 | 42 | $4,670 |
| Levetiracetam Generic | 231 | 420 | 39 | $7,795 |
| Sumatriptan Succinate Generic | 228 | 272 | 46 | $41K |
| Dalfampridine Er Dalfampridine | 213 | 290 | 28 | $189K |
| Tizanidine Hcl Generic | 212 | 287 | 44 | $2,516 |
| Aimovig Autoinjector Erenumab-Aooe | 208 | 248 | 26 | $177K |
| Rizatriptan Rizatriptan Benzoate | 145 | 157 | 29 | $2,464 |
| Clonazepam Generic | 143 | 169 | 29 | $1,041 |
| Nurtec Odt Rimegepant Sulfate | 142 | 144 | 30 | $190K |
| Propranolol Hcl Generic | 137 | 291 | 31 | $3,820 |
Brand drugs: 1,360 claims; generic drugs: 6,743 claims; opioid claims: 41.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Allen D Pettee $126 ($126 in general payments such as food, travel and fees) from 5 companies. The largest payer was Supernus Pharmaceuticals, Inc. with $30.62.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.